Best Direct Primary Care GLP-1 Providers in 2026: Ranked and Reviewed
Insurance billing comes out of the model entirely in Direct Primary Care (DPC), replaced by a flat monthly fee paid to the practice. A small and growing set of DPC practices now put GLP-1 weight-loss medication inside that membership at wholesale or close to it. Set that against the direct-to-consumer marketplace pattern, where the medication alone runs $300-$500/month and no continuing primary-care relationship comes with it. Lab monitoring, dose adjustments and side-effect management all sit inside one ongoing provider relationship here, which most clinicians treat as the standard to aim for in chronic weight management. Expect a membership fee of $50-$150/month, with wholesale GLP-1 on top at $65-$300/month depending on the drug, the dose and the form. Where insurance will not cover brand-name Wegovy or Zepbound, this can be the cheapest total path to a GLP-1 plus comprehensive care.
3 providers compared
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
3 direct primary care GLP-1 providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
pairing a compounded GLP-1 with unlimited primary care and labs in one membership
From /moCheck pricingScales with doseCoverage17 states + DCMedicationsSemaglutideTirzepatide - Nationwide Coverage
pharmacy-cost GLP-1 pricing once its membership opens
From /moCheck pricingScales with doseCoverage50 states + DCMedicationsSemaglutideTirzepatide Nevada residents who want a named physician, labs first and pass-through medication pricing
From /moCheck pricingCoverage1 stateMedications—
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick pairing a compounded GLP-1 with unlimited primary care and labs in one membership | Check pricing Scales by dose | SemaglutideTirzepatide | 17 states + DC | Visit → | |
Nationwide Coverage pharmacy-cost GLP-1 pricing once its membership opens | Check pricing Scales by dose | SemaglutideTirzepatide | 50 states + DC | Visit → | |
LL LiveNow LongevityNevada residents who want a named physician, labs first and pass-through medication pricing | Check pricing | — | 1 state | Visit → |
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
Detailed Reviews
Primary Clinic (Direct GLP)
Best for: pairing a compounded GLP-1 with unlimited primary care and labs in one membership
Primary Clinic sells a Direct Primary Care membership, not a GLP-1 package. $89 a month covers unlimited virtual visits, texting your provider, routine labs and many medications, with a three-month minimum. Members then buy compounded semaglutide from $85 a month and tirzepatide from $133 at what it calls wholesale cost, priced by dose band. It is run by Georgia Primary Care LLC of Tulsa, Oklahoma, and serves 18 listed states, DC among them.
Score Breakdown
Pros
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓We found no FDA warning letters issued to Primary Clinic (Direct GLP)
Cons
- ✗Serves only 17 states and DC, so check that yours is one of them
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Welling Health
Best for: pharmacy-cost GLP-1 pricing once its membership opens
Welling Health, run by Welling PLLC of Tacoma, WA, has rebuilt itself as a membership clinic that sells medication at the pharmacy's cost with no markup and bills each clinician visit separately. Its price sheet lists compounded semaglutide from $94 and tirzepatide from $135 at the starting dose, with the price following the dose. Prescribing is not open: in October 2026 its site said Rx was not yet open and membership pricing would open soon.
Score Breakdown
Pros
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes shipping
- ✓Serves all 50 states and DC
- ✓We found no FDA warning letters issued to Welling Health
Cons
- ✗Not included in the monthly price: clinician visits
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
LiveNow Longevity
Best for: Nevada residents who want a named physician, labs first and pass-through medication pricing
Score breakdown, pros and cons
LiveNow Longevity is a Las Vegas physician practice led by a board-certified neurologist that prescribes GLP-1 medications such as semaglutide and tirzepatide, plus peptides, for Nevada residents in clinic or by video. Care starts with an $88 evaluation that is credited toward your plan; medication is billed at the pharmacy's cost with no markup, and the management fee is quoted after the visit rather than published.
Score Breakdown
Pros
- ✓We found no FDA warning letters issued to LiveNow Longevity
- ✓Baseline bloodwork is required before a prescription
Cons
- ✗You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- ✗Serves one state only, so check that it is yours
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Frequently Asked Questions
Sources & methodology — as of November 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.